Fulton Breakefield Broenniman’s iShares iBonds Dec 2033 Term Corporate ETF IBDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
66,715
+7,912
+13% +$204K 0.1% 82
2026
Q1
$1.52M Buy
58,803
+8,153
+16% +$213K 0.1% 82
2025
Q4
$1.32M Buy
50,650
+3,407
+7% +$89.3K 0.08% 85
2025
Q3
$1.24M Buy
47,243
+4,315
+10% +$112K 0.08% 90
2025
Q2
$1.11M Buy
42,928
+33,078
+336% +$839K 0.08% 91
2025
Q1
$252K Buy
9,850
+1,490
+18% +$37.7K 0.02% 158
2024
Q4
$210K Buy
+8,360
New +$214K 0.02% 184

Other funds holding IBDY

Fulton Breakefield Broenniman's IBDY Position: Q2 2026 in Review

Fulton Breakefield Broenniman increased its iShares iBonds Dec 2033 Term Corporate ETF (IBDY) stake by 13% in Q2 2026, buying an estimated $204K and bringing the position to 66,715 shares worth $1.72M. The position accounts for 0.1% of the portfolio, ranked #82.

Fulton Breakefield Broenniman first reported a position in IBDY in Q4 2024 and has held it in 7 quarters since. 168 funds tracked by Wall St. Rank hold IBDY as of Q2 2026.

  • Fulton Breakefield Broenniman held 66,715 shares of iShares iBonds Dec 2033 Term Corporate ETF worth $1.72M as of Q2 2026.
  • Fulton Breakefield Broenniman bought 7,912 iShares iBonds Dec 2033 Term Corporate ETF shares in Q2 2026, an estimated $204K.
  • iShares iBonds Dec 2033 Term Corporate ETF made up 0.1% of Fulton Breakefield Broenniman's portfolio in Q2 2026, its #82 holding.
  • Fulton Breakefield Broenniman first reported a position in iShares iBonds Dec 2033 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 168 funds tracked by Wall St. Rank held iShares iBonds Dec 2033 Term Corporate ETF as of Q2 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.